| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/05/2012 | WO2012001469A1 Desmopressin for reducing nocturnal voids |
| 01/05/2012 | WO2012001403A1 Topical pharmaceutical composition comprising flurbiprofen |
| 01/05/2012 | WO2012001298A1 Cosmetic composition comprising peba |
| 01/05/2012 | WO2012001156A2 Pharmaceutical oral dosage forms comprising dabigatran etexilate and its pharmaceutically acceptable salts |
| 01/05/2012 | WO2012001089A1 Antibiotic compositions |
| 01/05/2012 | WO2012001076A1 Use of squaramide in the prevention and/or treatment of rosacea |
| 01/05/2012 | WO2012001074A2 Pharmaceutical compositions comprising 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one lactate monohydrate. |
| 01/05/2012 | WO2012001011A1 Method and device for producing vesicles |
| 01/05/2012 | WO2012001009A1 Polymeric system for delivering a preservative-free prostaglandin-based nonviscous solution |
| 01/05/2012 | WO2012000981A1 Pharmaceutical composition comprising drospirenone and contraceptive kit |
| 01/05/2012 | WO2012000971A2 Compositions with a high active ingredient fraction of pharmaceutically active substances |
| 01/05/2012 | WO2012000926A1 Silodosin-cyclodextrin inclusion compounds |
| 01/05/2012 | WO2012000757A1 Particles comprising hydrophobic polymer and hydrophobic phenolic compound |
| 01/05/2012 | WO2012000306A1 Phenyl nitrone compounds containing stilbene segment and use thereof |
| 01/05/2012 | WO2012000253A1 Composition for injection comprising docetaxel and preparation method thereof |
| 01/05/2012 | WO2012000113A1 Keloid treatment |
| 01/05/2012 | WO2012000104A1 Non-liposomal systems for nucleic acid delivery |
| 01/05/2012 | WO2011141863A3 Gaseous nitric oxide-sequestering products and processes of preparing same |
| 01/05/2012 | WO2011134679A9 Selected plant extracts for the treatment of inflammatory diseases |
| 01/05/2012 | WO2011131947A3 A process for particle processing of active pharmaceutical ingredients |
| 01/05/2012 | WO2011127458A3 Systems and methods of cell activated, controlled release delivery of growth factors for tissue repair and regeneration |
| 01/05/2012 | WO2011112558A3 Solid compositions |
| 01/05/2012 | WO2011109834A3 Enhancement of skeletal muscle stem cell engrafment by dual delivery of vegf and igf-1 |
| 01/05/2012 | WO2011109365A3 Concentrated protein formulations and uses thereof |
| 01/05/2012 | WO2011107970A3 Rifaximin powder, process for preparing the same and controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect. |
| 01/05/2012 | WO2011091167A3 Lysophosphatidic acid receptor targeting for scleroderma and other fibrotic diseases |
| 01/05/2012 | WO2011088229A3 Active self-healing biomaterial system |
| 01/05/2012 | WO2011067667A3 Fexofenadine microcapsules and compositions containing them |
| 01/05/2012 | WO2011064316A3 Mucosal delivery compositions comprising a peptide complexed with a crown comppound and/or a counter ion |
| 01/05/2012 | WO2011059324A3 Composition for topical application, uses thereof, applicator device and kit of parts |
| 01/05/2012 | WO2011055139A3 Antimicrobial and anti-acne formulations |
| 01/05/2012 | WO2011048379A3 Composition for inhalation |
| 01/05/2012 | WO2011045760A3 Micronized olmesartan medoxomil compositions |
| 01/05/2012 | WO2010134846A8 Substituted 8-sulfonyl-2,3,4,5-tetrahydro-1h-gamma-carbolines, ligands and pharmaceutical composition; method for the production and use of same |
| 01/05/2012 | US20120004642 In vitro micro-organs, and uses related thereto |
| 01/05/2012 | US20120004636 Hemostatic fibrous material |
| 01/05/2012 | US20120004531 Innately Multimodal Nanoparticles |
| 01/05/2012 | US20120004323 Implant processing methods for thermally labile and other bioactive agents and implants prepared from same |
| 01/05/2012 | US20120004318 Modified release formulations of memantine oral dosage forms |
| 01/05/2012 | US20120004177 Compositions and methods of delivery of pharmacological agents |
| 01/05/2012 | US20120004176 Liquid Composition of Factor VII Polypeptides |
| 01/05/2012 | US20120004170 Formulation Comprising Bioactive Agents And Method Of Using Same |
| 01/05/2012 | US20120003367 Dietary fiber composition |
| 01/05/2012 | US20120003337 Health supplements containing phyto-oestrogens, analogues or metabolites thereof |
| 01/05/2012 | US20120003324 Methods and Apparatus for Manufacturing Plasma Based Plastics and Bioplastics Produced Therefrom |
| 01/05/2012 | US20120003322 Ph-sensitive dendritic polymeric micelles |
| 01/05/2012 | US20120003321 Crosslinked Dextran Composite Magnetic Microparticles and Preparation Process and Using Method Thereof |
| 01/05/2012 | US20120003320 Particles which are surface coated with hyaluronan or one of the derivatives thereof and the use of same as biological vectors for active substances |
| 01/05/2012 | US20120003319 Compositions for site-specific delivery of imatinib and methods of use |
| 01/05/2012 | US20120003318 Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration |
| 01/05/2012 | US20120003317 Stable probiotic granulate, and method for preparing same |
| 01/05/2012 | US20120003316 Transmucosal delivery system |
| 01/05/2012 | US20120003315 Flowable Carrier Matrix |
| 01/05/2012 | US20120003314 Delayed-release oral pharmaceutical composition for treatment of colonic disorders |
| 01/05/2012 | US20120003313 Dpp iv inhibitor formulations |
| 01/05/2012 | US20120003312 Multilayer Minitablets with Different Release Rates |
| 01/05/2012 | US20120003311 Method for controlled release of an acid-unstable physiologically active substance |
| 01/05/2012 | US20120003310 Delayed release rasagiline formulation |
| 01/05/2012 | US20120003309 Solid Dosage Forms Of Bendamustine |
| 01/05/2012 | US20120003308 Pharmaceutical Composition Comprising Aliskiren |
| 01/05/2012 | US20120003307 Levetiracetam controlled release composition |
| 01/05/2012 | US20120003306 Pharmaceutical composition of nanoparticles for protein drug delivery |
| 01/05/2012 | US20120003305 Oral Dosage Forms Of Bendamustine |
| 01/05/2012 | US20120003304 Solid Forms |
| 01/05/2012 | US20120003303 Oral enteric antidepressant formulation |
| 01/05/2012 | US20120003302 Pharmaceutical composition containing a fermented, dehydrated material with amorphous crystalline structure |
| 01/05/2012 | US20120003301 Tissue markings and methods for reversibly marking tissue employing the same |
| 01/05/2012 | US20120003300 Composition Comprising Vascular Endothelial Growth Factor (VEGF) for the Treatment of Hair Loss |
| 01/05/2012 | US20120003299 Novel hsp90-targeted anti-cancer chimeric peptide |
| 01/05/2012 | US20120003298 Methods for inducing an immune response |
| 01/05/2012 | US20120003297 Compositions and methods for treating lymphoma |
| 01/05/2012 | US20120003296 New methods of treating dry eye syndrome |
| 01/05/2012 | US20120003295 Lipid a and other carbohydrate ligand analogs |
| 01/05/2012 | US20120003294 Fixed ratio camptothecens/platinum agents |
| 01/05/2012 | US20120003292 Anti-inflammatory dissolvable film |
| 01/05/2012 | US20120003291 Nanobead releasing medical devices |
| 01/05/2012 | US20120003290 Method for reducing pain |
| 01/05/2012 | US20120003288 Dispersion composition and method for manufacturing dispersion composition |
| 01/05/2012 | US20120003285 Method for manufacturing capsule series, and related capsule series |
| 01/05/2012 | US20120003283 Injectable Biomaterials |
| 01/05/2012 | US20120003282 Pharmaceutical compositions of dextran polymer derivatives |
| 01/05/2012 | US20120003280 Ceramic/structural protein composites and method of preparation thereof |
| 01/05/2012 | US20120003279 Methods and Apparatus for Manufacturing Plasma Based Plastics and Bioplastics Produced Therefrom |
| 01/05/2012 | US20120003278 Single-walled carbon nanotube/sirna complexes and methods related thereto |
| 01/05/2012 | US20120003277 Nanoemulsion vaccines |
| 01/05/2012 | US20120003275 Compositions and Methods for the Treatment of Ophthalmic Disease |
| 01/05/2012 | US20120003274 Oral sustained release antidepressant formulation |
| 01/05/2012 | US20120003273 Substituted benzfurochromenes and related compounds for the prevention and treatment of bone related disorders |
| 01/05/2012 | US20120003217 Herceptin® aduvant therapy |
| 01/05/2012 | US20120003161 Use of inositol-tripyrophosphate in treating tumors and diseases |
| 01/05/2012 | US20120000998 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 01/05/2012 | US20120000808 Fragrance sampler insert |
| 01/05/2012 | DE102010026090A1 Preparing a matrix for a sublingual dosage form, preferably a tablet, comprises preparing a mixture of gum arabic and active ingredients, and extruding the obtained mixture |
| 01/05/2012 | CA2804760A1 Single-walled carbon nanotube/sirna complexes and methods related thereto |
| 01/05/2012 | CA2804413A1 Keloid treatment |
| 01/05/2012 | CA2804149A1 Nanoemulsion vaccines |
| 01/05/2012 | CA2804148A1 Transdermal drug delivery system containing donepezil |
| 01/05/2012 | CA2804147A1 Sustained release composition comprising an amine as active agent and a salt of a cyclic organic acid |
| 01/05/2012 | CA2804035A1 Implant processing methods for thermally labile and other bioactive agents and implants prepared from same |
| 01/05/2012 | CA2803998A1 Antibody formulations |